TIDMODX

RNS Number : 1341L

Omega Diagnostics Group PLC

01 September 2023

Omega Diagnostics Group plc

('Omega' or the 'Company')

Update on proposed Share Reorganisation

Omega (AIM: ODX), the specialist medical diagnostics company focused on industry-leading Health and Nutrition products, announces an update with regards its proposed Share Reorganisation as notified in the Company's Notice of Annual General Meeting, which was posted to shareholders on 11 August 2023.

Proposed Share Reorganisation

Having consulted with a number of shareholders post the announcement of 31 August, the board has decided not to proceed with the proposed Share Reorganisation and associated consolidation of the Ordinary Shares. The board will withdraw Resolution 8 set out in the Notice of AGM with regards the Share Reorganisation.

Accordingly, the issued share capital of the Company will remain unchanged at 237,685,180 ordinary shares of 4 pence each and 123,245,615 deferred shares of 0.9 pence each.

The Company remains well funded and the Directors reiterate that they have no need or intention to raise funds at this time.

Contacts:

 
  Omega Diagnostics Group PLC                                            www.omegadx.com 
  Jag Grewal, Chief Executive Officer                                    via Walbrook PR 
 
  finnCap Ltd                                                         Tel: 020 7220 0500 
  Geoff Nash / Edward Whiley / George Dollemore 
   (Corporate Finance) 
  Nigel Birks / Harriet Ward (ECM) 
 
  Walbrook PR Limited                         Tel: 020 7933 8780 or omega@walbrookpr.com 
  Paul McManus / Lianne Applegarth                            Mob: 07980 541 893 / 07584 
                                                                                 391 303 
  Sam Allen                                                           Mob: 07502 558 258

About Omega Diagnostics Group PLC

Omega (AIM: ODX) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

www.omegadx.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CARLBMLTMTTMMRJ

(END) Dow Jones Newswires

September 01, 2023 05:29 ET (09:29 GMT)

Omega Diagnostics (LSE:ODX)
Gráfica de Acción Histórica
De Abr 2024 a May 2024 Haga Click aquí para más Gráficas Omega Diagnostics.
Omega Diagnostics (LSE:ODX)
Gráfica de Acción Histórica
De May 2023 a May 2024 Haga Click aquí para más Gráficas Omega Diagnostics.